Bangkok Tenofovir Study
|2||Active, not recruiting||
Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
|3||Not yet recruiting||
Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus
† Study has passed its completion date and status has not been verified in more than two years.